Based on current trial populations and how the FDA has handled semaglutide and tirzepatide approvals, expected eligibility criteria are: BMI 30 , or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, OSA) Adults 18 and older Not pregnant or breastfeeding No history of MTC or MEN 2 Retatrutide will almost certainly launch at a high price point estimates suggest $1,200$1,500 per month at list price
This week, we shine a light on a Wausau-area business that is helping people achieve their weight loss goals to lead a healthier life
Notably, individuals with diabetic retinopathy should be aware that Wegovys clinical studies included precautions for this condition
Both remain on the World Anti-Doping Agency prohibited list, and this weeks vote has no bearing on that
Discuss with your healthcare provider how long you should be on the medication and what the plan is for after you stop taking it
There are no food restrictions , but eating a healthy diet will make you feel better and get improved results on the program
